| 1 | [SID74373423] | Active | AC50 | 0.9958 | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Cancer Stem Cells [AID449748, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | AC50 | 0.9958 [uM] | | BioAssay | Luminescence Cell-Based Dose Retest to Confirm Inhibitors of Cancer Stem Cells | | AID | 449748 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID74373423] | Active | AC50 | 2.057 | Dose Response HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP [AID463074, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | AC50 | 2.057 [uM] | | BioAssay | Dose Response HTS Screen to Identify Cytotoxic Compounds of HMLE_sh_eGFP | | AID | 463074 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID74373423] | Active | Potency | 7.3078 | qHTS for inhibitors of Vif-A3G interactions: Cherry picks counterscreen [AID651813, Type: confirmatory] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | Potency | 7.3078 [uM] | | BioAssay | qHTS for inhibitors of Vif-A3G interactions: Cherry picks counterscreen | | AID | 651813 | | BioAssay type | confirmatory | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 4 | [SID74373423] | Active | Potency | 8.1995 | qHTS for inhibitors of Vif-A3F interactions: Cherry picks counterscreen [AID651815, Type: confirmatory] | APOBEC3F gene product [Homo sapiens] [gi:22907044] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | Potency | 8.1995 [uM] | | BioAssay | qHTS for inhibitors of Vif-A3F interactions: Cherry picks counterscreen | | AID | 651815 | | BioAssay type | confirmatory | | Target | APOBEC3F gene product [Homo sapiens] [gi:22907044] | | PubMed | | | Data Table |  |
|
| 5 | [SID74373423] | Active | Potency | 8.9125 | qHTS for Inhibitors of Vif-A3F Interactions: qHTS [AID602313, Type: confirmatory] | APOBEC3F gene product [Homo sapiens] [gi:22907044] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | Potency | 8.9125 [uM] | | BioAssay | qHTS for Inhibitors of Vif-A3F Interactions: qHTS | | AID | 602313 | | BioAssay type | confirmatory | | Target | APOBEC3F gene product [Homo sapiens] [gi:22907044] | | PubMed | | | Data Table |  |
|
| 6 | [SID74373423] | Active | Potency | 12.9953 | qHTS for inhibitors of Vif-A3F interactions: Cherry picks [AID651814, Type: confirmatory] | APOBEC3F gene product [Homo sapiens] [gi:22907044] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | Potency | 12.9953 [uM] | | BioAssay | qHTS for inhibitors of Vif-A3F interactions: Cherry picks | | AID | 651814 | | BioAssay type | confirmatory | | Target | APOBEC3F gene product [Homo sapiens] [gi:22907044] | | PubMed | | | Data Table |  |
|
| 7 | [SID74373423] | Active | Potency | 12.9953 | qHTS for inhibitors of Vif-A3G interactions: Cherry picks [AID651812, Type: confirmatory] | APOBEC3G gene product [Homo sapiens] [gi:13399304] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | Potency | 12.9953 [uM] | | BioAssay | qHTS for inhibitors of Vif-A3G interactions: Cherry picks | | AID | 651812 | | BioAssay type | confirmatory | | Target | APOBEC3G gene product [Homo sapiens] [gi:13399304] | | PubMed | | | Data Table |  |
|
| 8 | [SID74373423] | Active | IC50 | 15.44 | High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media [AID449762, Type: confirmatory] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | IC50 | 15.44 [uM] | | BioAssay | High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media | | AID | 449762 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID74373423] | Active | Potency | 23.1093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 10 | [SID74373423] | Active | Potency | 23.1093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 11 | [SID74373423] | Active | Potency | 23.1093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 12 | [SID74373423] | Active | IC50 | 40.67 | A High Throughput Confirmatory Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in the absence of Glycerol [AID449764, Type: confirmatory] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | IC50 | 40.67 [uM] | | BioAssay | A High Throughput Confirmatory Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in the absence of Glycerol | | AID | 449764 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID74373423] | Active | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells [AID2717, Type: screening] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells | | AID | 2717 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID74373423] | Active | | | uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay [AID624204, Type: screening] | SENP1 gene product [Homo sapiens] [gi:7657550] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay | | AID | 624204 | | BioAssay type | screening | | Target | SENP1 gene product [Homo sapiens] [gi:7657550] | | PubMed | | | Data Table |  |
|
| 15 | [SID74373423] | Active | | | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) [AID2796, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2796 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 16 | [SID74373423] | Active | | | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) [AID2796, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2796 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 17 | [SID74373423] | Active | | | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) [AID2796, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2796 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 18 | [SID74373423] | Active | | | Luminescence-based cell-based high throughput confirmation assay for activators of the Aryl Hydrocarbon Receptor (AHR) [AID2845, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2845 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 19 | [SID74373423] | Active | | | Luminescence-based cell-based high throughput confirmation assay for activators of the Aryl Hydrocarbon Receptor (AHR) [AID2845, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2845 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 20 | [SID74373423] | Active | | | Luminescence-based cell-based high throughput confirmation assay for activators of the Aryl Hydrocarbon Receptor (AHR) [AID2845, Type: screening] | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Luminescence-based cell-based high throughput confirmation assay for activators of the Aryl Hydrocarbon Receptor (AHR) | | AID | 2845 | | BioAssay type | screening | | Target | aryl hydrocarbon receptor precursor [Homo sapiens] [gi:4502003] | | PubMed | | | Data Table |  |
|
| 21 | [SID74373423] | Active | | | Fluorescence-based cell-based high throughput confirmation assay for agonists of the vasopressin 1 receptor (V1R) [AID434964, Type: screening] | vasopressin V1a receptor [Homo sapiens] [gi:4502331] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based high throughput confirmation assay for agonists of the vasopressin 1 receptor (V1R) | | AID | 434964 | | BioAssay type | screening | | Target | vasopressin V1a receptor [Homo sapiens] [gi:4502331] | | PubMed | | | Data Table |  |
|
| 22 | [SID74373423] | Active | | | Fluorescence-based cell-based high throughput confirmation assay for agonists of the vasopressin 1 receptor (V1R) [AID434964, Type: screening] | vasopressin V1a receptor [Homo sapiens] [gi:4502331] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based high throughput confirmation assay for agonists of the vasopressin 1 receptor (V1R) | | AID | 434964 | | BioAssay type | screening | | Target | vasopressin V1a receptor [Homo sapiens] [gi:4502331] | | PubMed | | | Data Table |  |
|
| 23 | [SID74373423] | Active | | | Fluorescence-based cell-based high throughput confirmation assay for agonists of the vasopressin 1 receptor (V1R) [AID434964, Type: screening] | vasopressin V1a receptor [Homo sapiens] [gi:4502331] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based high throughput confirmation assay for agonists of the vasopressin 1 receptor (V1R) | | AID | 434964 | | BioAssay type | screening | | Target | vasopressin V1a receptor [Homo sapiens] [gi:4502331] | | PubMed | | | Data Table |  |
|
| 24 | [SID74373423] | Active | | | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) [AID2797, Type: screening] | vasopressin V1a receptor [Homo sapiens] [gi:4502331] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) | | AID | 2797 | | BioAssay type | screening | | Target | vasopressin V1a receptor [Homo sapiens] [gi:4502331] | | PubMed | | | Data Table |  |
|
| 25 | [SID74373423] | Active | | | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) [AID2797, Type: screening] | vasopressin V1a receptor [Homo sapiens] [gi:4502331] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) | | AID | 2797 | | BioAssay type | screening | | Target | vasopressin V1a receptor [Homo sapiens] [gi:4502331] | | PubMed | | | Data Table |  |
|
| 26 | [SID74373423] | Active | | | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) [AID2797, Type: screening] | vasopressin V1a receptor [Homo sapiens] [gi:4502331] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) | | AID | 2797 | | BioAssay type | screening | | Target | vasopressin V1a receptor [Homo sapiens] [gi:4502331] | | PubMed | | | Data Table |  |
|
| 27 | [SID74373423] | Active | | | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set [AID624256, Type: screening] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set | | AID | 624256 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID74373423] | Active | | | Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1) [AID504766, Type: screening] | NR0B1 gene product [Homo sapiens] [gi:5016090] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1) | | AID | 504766 | | BioAssay type | screening | | Target | NR0B1 gene product [Homo sapiens] [gi:5016090] | | PubMed | | | Data Table |  |
|
| 29 | [SID74373423] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 30 | [SID74373423] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 31 | [SID74373423] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624127, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624127 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 32 | [SID74373423] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624127, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624127 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 33 | [SID74373423] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624127, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624127 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 34 | [SID74373423] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 35 | [SID74373423] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 36 | [SID74373423] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 37 | [SID74373423] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 38 | [SID74373423] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 39 | [SID74373423] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 40 | [SID74373423] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 41 | [SID74373423] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 42 | [SID74373423] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 43 | [SID74373423] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 44 | [SID74373423] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 45 | [SID74373423] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 46 | [SID74373423] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 47 | [SID74373423] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 48 | [SID74373423] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 49 | [SID74373423] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 50 | [SID74373423] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 74373423 | | CID | 56603523 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|